Abbott Targets Kremers Over Niaspan Clone
Abbott Laboratories on Friday continued its crusade to protect its cholesterol drug Niaspan by filing a lawsuit against Kremers Urban Pharmaceuticals Inc., accusing the company of infringing Abbott's patents through its...To view the full article, register now.
Already a subscriber? Click here to view full article